Compare
LivaNova PLC vs Conmed Corp vs Integer Holdings Corp vs TransMedics Group, Inc.
| Latest fiscal year | LivaNova PLC LIVN | Conmed Corp CNMD | Integer Holdings Corp ITGR | TransMedics Group, Inc. TMDX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.39B | $1.37B | $1.85B | $605.49M |
| Revenue growth (YoY) | +10.7% | +5.2% | +8.0% | +37.1% |
| Gross margin | 67.7% (computed) | 54.6% | 27.0% | 59.9% |
| Operating margin | 14.4% | 7.5% | 11.9% | 17.9% |
| Net margin | -17.5% | 3.4% | 5.5% | 31.4% |
| Net income | -$242.47M | $47.05M | $102.81M | $190.29M |
| EPS (Diluted) | -$4.45 | $1.51 | $2.89 | $4.87 |
| Operating cash flow | $254.34M | $170.69M | $196.15M | $192.84M |
| Free cash flow | $173.29M | $150.88M | $105.12M | $133.59M |
| Cash & equivalents | $635.55M | n/a | $17.16M | n/a |
| Total assets | $2.61B | $2.33B | $3.41B | $1.07B |
| Total liabilities | $1.41B | $1.29B | $1.66B | $595.27M |
| Shareholders' equity | $1.20B | $1.03B | $1.75B | $473.10M |
| Return on year-end equity | -20.2% | 4.6% | 5.9% | 40.2% |
| Shares outstanding | 54.65M | n/a | 34.35M | 34.27M |
Revenue, most recent five fiscal years
| Fiscal year | LivaNova PLC | Conmed Corp | Integer Holdings Corp | TransMedics Group, Inc. |
|---|---|---|---|---|
| Latest | $1.39B Ended 2025-12-31 | $1.37B Ended 2025-12-31 | $1.85B Ended 2025-12-31 | $605.49M Ended 2025-12-31 |
| 1 year earlier | $1.25B Ended 2024-12-31 | $1.31B Ended 2024-12-31 | $1.72B Ended 2024-12-31 | $441.54M Ended 2024-12-31 |
| 2 years earlier | $1.15B Ended 2023-12-31 | $1.24B Ended 2023-12-31 | $1.56B Ended 2023-12-31 | $241.62M Ended 2023-12-31 |
| 3 years earlier | $1.02B Ended 2022-12-31 | $1.05B Ended 2022-12-31 | $1.33B Ended 2022-12-31 | $93.46M Ended 2022-12-31 |
| 4 years earlier | $1.04B Ended 2021-12-31 | $1.01B Ended 2021-12-31 | $1.22B Ended 2021-12-31 | $30.26M Ended 2021-12-31 |